Sign in
4

Changes in Ownership

Estrella Immunopharma, Inc. Filed Acc 0002163153-26-000002

Options or other derivatives

  • Chief Executive Officer acquired 1,000,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Pussinen Cynthia · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-02 Grant or award : show line 1 in the form Stock Option (Right to Buy) +1,000,000 1,000,000 D
Loading xslF345X06/primary_doc.xml…